Nordic News, Business and Life in Asia
Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, Huang Zhenhua, alleging KBP Biosciences misrepresented the effectiveness of an experimental hypertension drug, …
Novo Nordisk sues Singapore biotech firm over $1.3 billion acquisition dispute Read More
Novo Nordisk has established itself in the medicine market with patents that earn billions. Mainly due to the obesity drug Wegovy and the diabetes medicine Ozempic. Both consists of an …
Approaching patent expiration in China may threaten Novo’s billion-dollar business Read More
Danish pharmaceutical company Novo Nordisk has surpassed LVMH and is now Europe’s most valuable listed company. LVMH, the world’s biggest luxury retailer, is currently suffering due to growing concerns about …
Danish Novo Nordisk surpasses LVMH as Europe’s most valuable company Read More
Novo Nordisk’s obesity medicine Wegovy reduces the risk of heart attacks and strokes according to a highly anticipated study. People with obesity or are overweight with a history of heart …
Novo Nordisk is now second biggest firm in Europe after study finds that Wegovy cuts risk of heart attacks Read More
Health Sciences Authority (HSA) in Singapore has given the green light to Wegovy. Wegovy is the weight-loss drug by Danish pharmaceutical company Novo Nordisk, that has gained huge popularity on …
Singapore approves Danish weight-loss drug Read More
Novo Nordisk Pharmatech, part of the Novo Nordisk group, has purchased a 47,000 square meter site in Koge, Denmark. The goal is to expand production, the company said on Friday. …
Novo Nordisk aims to expand production Read More
Novo Nordisk’s diabetes drug Ozempic has become a social media phenomenon for its weight loss effects. Its sky-high popularity has led to global shortage and doctors warn about the potential …
Doctors worried about Danish weight loss drug trending on TikTok Read More
According to an announcement from Novo Holdings, the Danish holding company has joined the US$ 80 million Series C financing in Halodoc, an Indonesia-based health tech platform, media PR Newswire …
Novo Holdings makes its first investment in an Asian health tech company Read More